US 10239837
Piperidine derivatives as HDAC1/2 inhibitors
granted A61PA61P35/00A61P35/02
Quick answer
US patent 10239837 (Piperidine derivatives as HDAC1/2 inhibitors) held by Regenacy Pharmaceuticals, Inc. expires Mon Mar 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Regenacy Pharmaceuticals, Inc.
- Grant date
- Tue Mar 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61P, A61P35/00, A61P35/02, A61P43/00, A61P7/00